| 000 | 01888 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515044021.0 | ||
| 264 | 0 | _c20070103 | |
| 008 | 200701s 0 0 eng d | ||
| 022 | _a1360-2276 | ||
| 024 | 7 |
_a10.1111/j.1365-3156.2006.01726.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMulenga, Modest | |
| 245 | 0 | 0 |
_aA randomised, double-blind, placebo-controlled trial of atovaquone-proguanil vs. sulphadoxine-pyrimethamine in the treatment of malarial anaemia in Zambian children. _h[electronic resource] |
| 260 |
_bTropical medicine & international health : TM & IH _cNov 2006 |
||
| 300 |
_a1643-52 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnemia _xdrug therapy |
| 650 | 0 | 4 |
_aAntimalarials _xadverse effects |
| 650 | 0 | 4 |
_aAtovaquone _xadverse effects |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aMalaria, Falciparum _xcomplications |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aParasitemia _xcomplications |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 |
_aProguanil _xadverse effects |
| 650 | 0 | 4 |
_aPyrimethamine _xadverse effects |
| 650 | 0 | 4 |
_aSulfadoxine _xadverse effects |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Failure |
| 650 | 0 | 4 |
_aZambia _xepidemiology |
| 700 | 1 | _aMalunga, Fidelis | |
| 700 | 1 | _aBennett, Steve | |
| 700 | 1 | _aThuma, Philip E | |
| 700 | 1 | _aShulman, Caroline | |
| 700 | 1 | _aFielding, Katherine | |
| 700 | 1 | _aAlloueche, Ali | |
| 700 | 1 | _aGreenwood, Brian M | |
| 773 | 0 |
_tTropical medicine & international health : TM & IH _gvol. 11 _gno. 11 _gp. 1643-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-3156.2006.01726.x _zAvailable from publisher's website |
| 999 |
_c16629967 _d16629967 |
||